What is Vaidyane Ayurved Laboratories Quick Ratio?
Vaidyane Ayurved LaboratoriesNSE:MADHAVBAUG 84 Quick Ratio is 3.66 as of Mar. 2026, which is 98% above its 10-year median of 1.85. GuruFocus rates NSE:MADHAVBAUG with a GF Score™ of 84/100 and a GF Value™ of ₹228.10 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 996 Drug Manufacturers companies, Vaidyane Ayurved Laboratories ranks better than 82.13% on this metric.
Vaidyane Ayurved Laboratories has a quick ratio of 3.66. It generally indicates good short-term financial strength.
The historical rank and industry rank for Vaidyane Ayurved Laboratories's Quick Ratio or its related term are showing as below:
NSE:MADHAVBAUG'
s Quick Ratio Range Over the Past 10 Years
Min: 0.3 Med: 1.85 Max: 3.66
Current: 3.66
During the past 8 years, Vaidyane Ayurved Laboratories's highest Quick Ratio was 3.66. The lowest was 0.30. And the median was 1.85.
NSE:MADHAVBAUG's Quick Ratio is ranked better than 82.13% of 996
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs NSE:MADHAVBAUG: 3.66
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Vaidyane Ayurved Laboratories Quick Ratio Related Terms
Vaidyane Ayurved Laboratories Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MADHAVBAUG vs ZTS, UTHR: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaidyane Ayurved Laboratories Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Vaidyane Ayurved Laboratories's Quick Ratio falls into.
Vaidyane Ayurved Laboratories Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a Quick Ratio of 3.66 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Vaidyane Ayurved Laboratories and its competitors. This is 98% above median its historical median of 1.85. Over the past decade, Vaidyane Ayurved Laboratories' Quick Ratio has ranged from 0.30 to 3.66. According to the industry distribution chart, Vaidyane Ayurved Laboratories ranks #178 out of 996 companies in the Drug Manufacturers industry, placing it in the top 17.9%.
Is Vaidyane Ayurved Laboratories' Quick Ratio too high?
Vaidyane Ayurved Laboratories' current Quick Ratio of 3.66 is 98% above median its 10-year median of 1.85. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 3.66. The Drug Manufacturers industry median Quick Ratio is 1.45. Vaidyane Ayurved Laboratories' value of 3.66 is 152.4% above this industry median. Based on the distribution chart, Vaidyane Ayurved Laboratories ranks #178 out of 996 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vaidyane Ayurved Laboratories ranks #178 out of 996 companies for Quick Ratio. This places Vaidyane Ayurved Laboratories in the top 18% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Vaidyane Ayurved Laboratories' value of 3.66 is 152.4% above this benchmark. Historically, Vaidyane Ayurved Laboratories' own Quick Ratio has ranged from 0.30 to 3.66 over the past decade. While the company's 10-year median is 1.85 vs. the industry median of 1.45, Vaidyane Ayurved Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaidyane Ayurved Laboratories's current Quick Ratio of 3.66 is 152.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Vaidyane Ayurved Laboratories and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaidyane Ayurved Laboratories's current Quick Ratio is 3.66, which is 98% above median its own 10-year median of 1.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹228.10, compared to a current price of ₹182.00 — trading 20.2% below its estimated fair value. The current Quick Ratio is 3.66, which is 98% above median its 10-year median of 1.85 and 152.4% above the Drug Manufacturers industry median of 1.45. Vaidyane Ayurved Laboratories' overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current Quick Ratio is 3.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued.
The current stock price of ₹182.00 is trading 20.2% below its estimated GF Value™ of ₹228.10.
GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:MADHAVBAUG:
Quick Ratio: 3.66 (98% above median its 10-year median of 1.85)
GF Value™: ₹228.10 vs. price of ₹182.00 (20.2% below fair value)
Industry Position: 152.4% above the Drug Manufacturers median (#178 of 996)
No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaidyane Ayurved Laboratories Business Description
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
84GF Score
Get the complete analysis for NSE:MADHAVBAUG
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MADHAVBAUG has been successfully added to your 
